Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Auer

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Nature Communications|May 12, 2021
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccinationD G Roy, K Geoffroy, M Marguerie, et al.
Cancer Immunology Research|February 5, 2017
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular VaccineAlmohanad A Alkayyal, Lee-Hwa Tai, Michael A Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeuticJulia L Rintoul, Chantal G Lemay, Lee-Hwa Tai, et al.
Surgical Endoscopy|October 4, 2022
Patient and surgeon preferences for early ileostomy closure following restorative proctectomy for rectal cancer: why aren't we doing it?Natasha G Caminsky, Jeongyoon Moon, Nancy Morin, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2014
Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic diseaseJiqing Zhang, Lee-Hwa Tai, Carolina S Ilkow, et al.
Scientific Reports|June 11, 2023
Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade gliomaP Rauch, H Stefanits, M Aichholzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Nature Communications|May 12, 2021
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccinationD G Roy, K Geoffroy, M Marguerie, et al.
Cancer Immunology Research|February 5, 2017
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular VaccineAlmohanad A Alkayyal, Lee-Hwa Tai, Michael A Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeuticJulia L Rintoul, Chantal G Lemay, Lee-Hwa Tai, et al.
Surgical Endoscopy|October 4, 2022
Patient and surgeon preferences for early ileostomy closure following restorative proctectomy for rectal cancer: why aren't we doing it?Natasha G Caminsky, Jeongyoon Moon, Nancy Morin, et al.
BMJ (Clinical Research Ed.)|September 13, 2022
Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trialRebecca C Auer, Michael Ott, Paul Karanicolas, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare SystemFelix E G Beaudry, Zhihao Li, Ayelet Borgida, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2014
Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic diseaseJiqing Zhang, Lee-Hwa Tai, Carolina S Ilkow, et al.
Scientific Reports|June 11, 2023
Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade gliomaP Rauch, H Stefanits, M Aichholzer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaquesLaura Evgin, Sergio A Acuna, Christiano Tanese de Souza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccineChantal G Lemay, Julia L Rintoul, Agnieszka Kus, et al.
Pageof 16